Nippon Sanso Elevates Spanish Homecare Unit to Specified Subsidiary After Acquisition

Nippon Sanso Holdings Corporation ( (JP:4091) ) has provided an announcement.

Nippon Sanso Holdings has acquired Esteve Teijin Healthcare, S.L., a Spanish home healthcare services provider, via its local unit Oximesa S.L.U., and renamed the business Nippon Sanso Homecare España, S.L.U. Following a review of past capital transactions, the unit’s stated capital was found to exceed 10% of the parent’s capital, elevating it to the status of a specified subsidiary under Japanese disclosure rules.

The Spanish subsidiary, established in 2009 and wholly owned through Oximesa, reported steady growth with 2024 net sales of €40 million and net assets of €36 million, supporting Nippon Sanso’s push into European home healthcare. The change, effective March 3, 2026, has already been factored into the group’s earnings forecast for the fiscal year ending March 31, 2026, suggesting no additional immediate impact on its financial outlook beyond what has been previously guided.

The most recent analyst rating on (JP:4091) stock is a Hold with a Yen5800.00 price target. To see the full list of analyst forecasts on Nippon Sanso Holdings Corporation stock, see the JP:4091 Stock Forecast page.

More about Nippon Sanso Holdings Corporation

Nippon Sanso Holdings Corporation, listed on the Tokyo Stock Exchange Prime Market, is a global industrial gas group expanding into healthcare-related services. Through its European subsidiaries, the company is building a presence in home healthcare, particularly in respiratory and related home-based medical support across European markets such as Spain.

Average Trading Volume: 839,059

Technical Sentiment Signal: Strong Buy

Current Market Cap: Yen2456.7B

Find detailed analytics on 4091 stock on TipRanks’ Stock Analysis page.